Czech/SlovakiaCzech RepublicSlovakia

Zentiva Plans Initial Public Offering

07.06.2004

Prague - The Czech generics pharmaceutical company Zentiva a.s. intends to seek a listing on the Prague and London Stock Exchanges through a global offering of shares and GDRs (Global Depositary Receipts). The shares are being offered in the Czech Republic. In the United States and elsewhere outside the Czech Republic shares and GDRs are only being offered to certain institutional investors. Merrill Lynch International has been appointed global co-ordinator, sole book runner and lead manager to the offer.
“We are delighted that Zentiva is to become a public company by being the first company to undertake a significant IPO on the Prague Stock Exchange. The offering will facilitate our strategy of expansion into
other key Central and Eastern European markets,” said Jiri Michal, chairman of the board and CEO of Zentiva. The company develops, manufactures and markets branded generic pharmaceutical products. It is one of the largest pharmaceutical companies in the region and on a combined basis the largest generic pharmaceutical supplier in its four core markets of the Czech Republic, Slovakia, Poland and Russia.
In August 2003, Zentiva increased its critical mass in Slovakia, Poland and Russia with the acquisition of Slovakia's largest generic player Slovakofarma. The former Leciva and Slovakofarma now market their pharmaceutical products under the name Zentiva in all markets. Based on IMS data Zentiva's market share by value for generic pharmaceutical products amounts to 51% in the Czech Republic and to 61% in Slovakia.

Czech/SlovakiaCzech RepublicSlovakia

07.03.2012

The Czech government has beefed up its investments in biotech with the help of EU structural funds. In February, the country’s Education Minister Josef Dobes gave the go-ahead for the Biocev centre in Vestec near Prague. Although...

Czech/SlovakiaCzech RepublicSlovakia

05.12.2011

Brno – Czech Prime Minister Petr Necas has officially inaugurated the first of six European Technology Institutes slated to be launched in the Czech Republic with help from European FEDER funds. Although construction of the €200m...

Czech/SlovakiaCzech RepublicSlovakia

01.10.2011

Prague – Czech drug developer VUAB Pharma a.s. has joined CzechBio. The company, which has its headquarters in Roztoky near Prague, became the 35th member of the Czech biotechnology industry association in September. VUAB...

Czech/SlovakiaCzech RepublicSlovakia

09.08.2011

Praque – A team of researchers headed by Dr. Valdimir Kral, Director of Chemical Development at Sanofi-Aventis’ Czech research unit Zentiva Development sro, has presented a new targeted drug delivery system that couples combined...

Czech/SlovakiaCzech RepublicSlovakia

01.06.2011

Brno – Plans for building a Central European Insitute of Technology (CEITEC) in Brno look set to take a big step closer to becoming reality. In mid-May, CEITEC representatives announced that EU financing for the EUR260m...

Czech/SlovakiaCzech RepublicSlovakia

03.11.2010

Plzen – Czech antibody discovery and development specialist AbCheck s.r.o. has signed its first contract with a big pharma company. In October, the yearling Czech spin-off from German antibody drug developer Affimed GmbH...

Czech/SlovakiaCzech RepublicSlovakia

13.09.2010

Prague – CzechInvest has called on Czech high-tech companies in the field of ICT, bio­technology, clean technology and micro­electronics to apply for the Czech Technology Accelerator programme. Under the third call, which was...

Czech/SlovakiaCzech RepublicSlovakia

02.07.2010

Prague – Czech researchers from Charles University in Prague have discovered a molecular biomarker that helps to predict toxicity and a higher risk for adverse effects in children with juvenile arthritis that are treated with...

Czech/SlovakiaCzech RepublicSlovakia

12.05.2010

Prague – Czech biotech company Lenti­Kats AS has begun worldwide commercialisation of a patented, cost-effective encapsulation technology for use in the food and bio­pharmaceuticals industry. The company has discovered a way to...

Czech/SlovakiaCzech RepublicSlovakia

12.05.2010

Sofia – Bulgaria’s parliament has approved a law that will in effect ban any cultivation of GMO crops in the country. “There will be no field on the country’s territory where GMOs can be cultivated,” said Kostadin Yazov from the...

Displaying results 1 to 10 out of 70

1-10 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive-czech-slovakia/article/zentiva-plans-initial-public-offering.html

Product of the week

Products

Events

All Events

Current issue

All issues